Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Hair Removal Duet
San Francisco -- Topical eflornithine hydrochloride 13.9 percent cream (Vaniqa) can be used safely by patients undergoing laser hair removal and may have added value for improving the response to photoepilation, especially early on, according to results of a double-blinded study presented by Stacy R. Smith, M.D., at the annual meeting of the American Academy of Dermatology.
Related Videos
Related Content
